203 related articles for article (PubMed ID: 18295617)
1. The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report.
Stubblefield MD; Levine A; Custodio CM; Fitzpatrick T
Arch Phys Med Rehabil; 2008 Mar; 89(3):417-21. PubMed ID: 18295617
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
[TBL] [Abstract][Full Text] [Related]
4. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
Opara J; Hordyńska E; Swoboda A
Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
[TBL] [Abstract][Full Text] [Related]
6. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
Guettard E; Roze E; Abada G; Lemesle C; Vidailhet M; Laurent-Vannier A; Chevignard MP
Dev Neurorehabil; 2009 Jun; 12(3):128-38. PubMed ID: 19466620
[TBL] [Abstract][Full Text] [Related]
7. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
[TBL] [Abstract][Full Text] [Related]
8. Development of resistance to botulinum toxin type A in patients with torticollis.
Greene P; Fahn S; Diamond B
Mov Disord; 1994 Mar; 9(2):213-7. PubMed ID: 8196686
[TBL] [Abstract][Full Text] [Related]
9. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
Mayer NH; Whyte J; Wannstedt G; Ellis CA
Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
[TBL] [Abstract][Full Text] [Related]
11. Repeated botulinum toxin injections can improve mobility in patients with spinal cord lesions.
Catz A; Barkol H; Steinberg F; Ronen J; Bluvshtein V; Keren O
Eura Medicophys; 2007 Sep; 43(3):319-25. PubMed ID: 17525702
[TBL] [Abstract][Full Text] [Related]
12. Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy.
Rivard PF; Nugent AC; Symons FJ
Clin J Pain; 2009 Jun; 25(5):413-7. PubMed ID: 19454875
[TBL] [Abstract][Full Text] [Related]
13. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
Sobolewski P
Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
[TBL] [Abstract][Full Text] [Related]
14. The use of a portable muscle tone measurement device to measure the effects of botulinum toxin type a on elbow flexor spasticity.
Chen JJ; Wu YN; Huang SC; Lee HM; Wang YL
Arch Phys Med Rehabil; 2005 Aug; 86(8):1655-60. PubMed ID: 16084822
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.
Gracies JM; Lugassy M; Weisz DJ; Vecchio M; Flanagan S; Simpson DM
Arch Phys Med Rehabil; 2009 Jan; 90(1):9-16.e2. PubMed ID: 19154823
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.
Hsiung GY; Das SK; Ranawaya R; Lafontaine AL; Suchowersky O
Mov Disord; 2002 Nov; 17(6):1288-93. PubMed ID: 12465070
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
Taylor M; Silva S; Cottrell C
Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin injection into Riolan's muscle: somatosensory 'trick'.
Inoue K; Rogers JD
Eur Neurol; 2007; 58(3):138-41. PubMed ID: 17622718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
